SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The December 2025 quarter revenue stood at Rs. 1494.81 millions, up 22.99% as compared to Rs. 1215.42 millions during the corresponding quarter last year.The Total Profit for the quarter ended December 2025 of Rs. 107.42 millions grew from Rs.-8.61 millionsOperating Profit saw a handsome growth to 329.78 millions from 157.04 millions in the quarter ended December 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 1494.81 1215.42 22.99 4479.13 4049.00 10.62 5496.47 16725.66 -67.14
Other Income 275.79 166.34 65.80 600.20 768.62 -21.91 812.75 882.95 -7.95
PBIDT 329.78 157.04 110.00 706.79 773.91 -8.67 683.35 3871.13 -82.35
Interest 6.74 100.27 -93.28 38.40 296.75 -87.06 29.18 1037.67 -97.19
PBDT 264.50 49.51 434.24 609.85 550.40 10.80 2886.21 6743.44 -57.20
Depreciation 88.35 58.12 52.01 224.90 170.42 31.97 244.79 804.10 -69.56
PBT 176.15 -8.61 -2145.88 384.95 379.98 1.31 2641.42 5939.34 -55.53
TAX 68.73 0.00 0.00 108.79 0.00 0.00 80.58 577.55 -86.05
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -38.26 -108.43 -64.71
PAT 107.42 -8.61 -1347.62 276.16 379.98 -27.32 2560.84 5361.79 -52.24
Equity 816.12 590.87 38.12 816.12 672.12 21.42 687.44 672.12 2.28
PBIDTM(%) 22.06 12.92 70.75 15.78 19.11 -17.44 12.43 23.14 -46.28

Ind-Swift Lab. Share Price

139.95 -4.50 (-3.12%)
07-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1834.40
Dr. Reddys Lab 1306.80
Cipla 1362.85
Zydus Lifesciences 940.10
Lupin 2459.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×